Digital Diagnostics Market Size is valued at USD 1.66 billion in 2023 and is predicted to reach USD 6.32 billion by the year 2031 at a 18.48% CAGR during the forecast period for 2024-2031.
Using a standardized tool, digital diagnostics enables quick issue isolation and resolution, facilitating collaboration throughout the application lifecycle. By improving the accuracy and precision of diagnostic results, this innovative technology aids in the advancement of the healthcare system. During the forecast period, the worldwide digital diagnostics market is anticipated to increase at a solid rate driven by growing healthcare expenditure, technical improvements, and increased attention. The need for improved diagnostic technologies that can offer individualized insights and treatment plans is being driven by rising healthcare costs, a growing understanding of the value of early diagnosis, and a move toward customized medicine.
However, there are issues that must be resolved, like expensive implementation costs and worries about data privacy. With ongoing technological breakthroughs and rising acceptance of digital health solutions, the market for digital diagnostics appears to have a bright future overall.
Competitive Landscape
Some of the major key players in the digital diagnostics market are
- Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Laboratory Corporation of America Holdings
- GE Healthcare
- Siemens Healthineers
- Medtronic plc
- Nano-X Imaging Ltd.
- Koninklijke Philips N.V.
- Digital Diagnostics Inc.
- Riverain Technologies
- VUNO Inc.
- AliveCor, Inc.
- Behold.ai
- Brainomix
- Healthy.io
- Canon Inc.
Market Segmentation:
The digital diagnostics market is segmented on the basis of product , application, and end-user. Product segment includes Hardware and Software. Application segment includes Cardiology, Oncology, Neurology, Pathology, and Others. End-user segment includes Hospitals, Clinical Laboratories, and Others.
Based On Application, The Oncology Segment Is Accounted As A Major Contributor To The Digital Diagnostics Market
The oncology category is expected to hold a major share in the global digital diagnostics market in 2022. The reason for this growth is the rising global prevalence of cancer. The market is also growing due to factors such as the increasing adoption of Digital Diagnostics platforms for cancer screening, technical innovation, and the surge in the introduction of new product releases. Furthermore, during the projection period, the Radiology category is anticipated to boost at the fastest CAGR. The benefits of digital radiography, such as instantaneous evaluation, editing, and magnification of the result, contrast and luminosity adjustment to produce the best image of the object under study, and the ability to preserve the result electronically or in print, would drive this expansion.
The Hospitals Segment Represented Growth At A Rapid Rate.
The hospital segment is projected to evolve at a rapid rate in the global digital diagnostics market. The widespread use of digital pathology and radiography in hospitals, clinics, and other digital diagnostic tools is driving this growth. Hospitals have access to CT scanners and computer-aided diagnosis systems. Another factor driving this market's expansion is the creation of artificial intelligence platforms that integrate with the healthcare system.
In The Region, The North American Digital Diagnostics Market Holds A Significant Revenue Share.
The North American digital diagnostics market is foreseen to exhibit the largest market share in terms of revenue in the near future. The increasing number of chronic illness cases in the North American region is driving this region's expansion. The Digital Diagnostics Industry Outlook in the North American region is being further enhanced by the rapidly increasing number of product debuts. In addition, Asia Pacific is anticipated to rise rapidly in the global digital diagnostics market. A few factors contributing to this growth are the rising costs of computer-aided diagnostics in healthcare in the Asia-Pacific area. The Asia-Pacific digital diagnostics market is expanding owing to the rising awareness of the benefits of these technologies.
Digital Diagnostics Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 1.66 Bn |
|
Revenue Forecast In 2031 |
USD 6.32 Bn |
|
Growth Rate CAGR |
CAGR of 18.48% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Application, and End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Riverain Technologies, Hoffmann-La Roche Ltd., GE Healthcare, Digital Diagnostics Inc., Siemens Healthcare GmbH, ThermoFisher Scientific Inc., Laboratory Corporation of America Holdings.VUNO Inc., AliveCor,Inc., Behold.ai, Brainomix, Healthy.io, Canon Inc. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
